Clinical trial No longer in our active list Interventional Ages 20 to 70

Comparing electroacupuncture and TENS for rheumatoid arthritis pain relief

Official title: Comparative Effectiveness Research of Electroacupuncture and Transcutaneous Electrical Nerve Stimulation in Patients With Rheumatoid Arthritis: A Pragmatic Randomized Clinical Trial

Run by China Medical University Hospital · NCT04521998 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether electroacupuncture or TENS can better relieve pain and improve quality of life for people with rheumatoid arthritis.

Quick facts

Study typeInterventional
Ages20 Years to 70 Years
SexAll
Enrollment80 (estimated)
SponsorChina Medical University Hospital
Academic / other
Locations1 site (Taichung)
Trial IDNCT04521998 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 20-70 who meet the American College of Rheumatology criteria for rheumatoid arthritis and are on a stable medication regimen.

Probably not a fit

Patients currently treated with biological agents or those with certain medical conditions, such as uncontrolled blood pressure or bleeding disorders, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to compare the effectiveness of electroacupuncture and transcutaneous electrical nerve stimulation (TENS) in reducing tenderness and improving quality of life in patients with rheumatoid arthritis. A total of 80 participants will be recruited and randomly assigned to receive either electroacupuncture or TENS, with both groups undergoing treatment twice a week for a total of 10 sessions. The study will assess pain severity and clinical symptoms using various scales to determine which intervention is more effective.

Why it matters

Potential benefit: If successful, this study could provide patients with effective non-pharmacological options for managing pain associated with rheumatoid arthritis.

How similar studies have gone: Previous studies have shown promising results for both electroacupuncture and TENS in managing pain, suggesting that this comparative approach could yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 20-70 years old
* Met the American College of Rheumatology criteria (2010) for RA
* Classification of X-ray : Stage I\~III
* The participants' RA medication regimen (DMARD, NSAID, steroid)were eligible if they were on a stable dose for at least 3 months before entry into and throughout the study.
* All patients were instructed not to make any changes in their background therapies during the study.
* Intra-articular or pulse steroid were not permitted during the study

Exclusion Criteria:

* Be treated with biological agents, such as antagonist of TNF-alpha, IL-6, Jak, and CD20 mono antibody in the last 3 months
* Having history of serious drug allergy
* Pregnancy or breastfeeding
* Bleeding or coagulation disorders
* Localized skin infections
* Uncontrolled or ill-controlled blood pressure with diastolic pressure≥110 mmHg
* Any other acupuncture treatment or herbal medication for RA within 2 weeks before screening
* needle phobia
* Intra-articular corticosteroid or pulse steroid within 4 weeks preceding the study
* Any severe chronic or uncontrolled comorbid disease

Where it's running

  • China Medical University Hospital
    Taichung, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Hung-Rong Yen, M.D. Ph.D. — China Medical University Hospital
  • Study coordinator: Hung-Rong Yen, M.D. Ph.D.
  • Email: hungrongyen@gmail.com
  • Phone: 886-4-22052121

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Collarless Actis hip stem for cementless hip replacement in Asian patients

    This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.

    Recruiting Seoul National University Bundang Hospital · Seongnam-si, Gyeonggi-do · NCT07828080

  • BMS-986528 in people with hard-to-treat rheumatoid arthritis

    This study tests BMS-986528 to see if it is safe and tolerable and to gather early data on how it behaves in the body and whether it might slow rheumatoid arthritis.

    Recruiting at 10 sites Phase 1/2 Bristol-Myers Squibb · La Jolla, California and 38 other locations · NCT07412704

  • Fucoidan for active rheumatoid arthritis

    This trial will test whether fucoidan, a seaweed-derived SR-A inhibitor, can reduce disease activity in adults (18–65) with active rheumatoid arthritis who have moderate-to-high disease activity despite current treatment.

    Recruiting Peking University People's Hospital · Beijing · NCT07045896

  • Abdominal vagus nerve stimulation for moderate to severe drug-refractory rheumatoid arthritis

    This trial will try a small implanted device that stimulates the abdominal vagus nerve to see if it is safe and possibly helpful for adults whose moderate to severe rheumatoid arthritis has not responded to medicines.

    Recruiting at 3 sites The Bionics Institute of Australia · Fitzroy, Victoria and 2 other locations · NCT07017686

  • Effects of phytocannabinoids on immune response in chronic inflammatory diseases

    This study is testing whether phytocannabinoids like CBD and THC can help improve the immune response in people with chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

    Recruiting Centre Hospitalier Régional d'Orléans · Orléans · NCT06842316

  • Individualized tapering strategy for rheumatoid arthritis treatment

    This study is testing a personalized plan for reducing medication in people with rheumatoid arthritis who are in remission to see if it helps prevent flare-ups.

    Recruiting at 6 sites Phase 4 Centre Hospitalier Universitaire de Saint Etienne · Caluire-et-Cuire and 7 other locations · NCT06528431

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.